Dr. Karin Gaensler, MD

Dr. Gaensler practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Gaensler's NPI, 1609830215, was assigned on April 12, 2006. Dr. Gaensler graduated from Harvard Medical School in 1981. Dr. Gaensler holds California license G50093.

Dr. Gaensler's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Gaensler's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Gaensler to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaensler practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gaensler's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Gaensler is board certified in hematology by the American Board of Internal Medicine. Dr. Gaensler is licensed in California.

Dmand AI lists chronic leukemia, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Gaensler treats.

CMS data shows 256 Medicare services from Dr. Gaensler across 3 procedure codes in 2024, for 72 Medicare patients. Medicare paid $17,704 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Gaensler in 2024. The largest group is 65 to 74, with 38 patients. 71% of them have high blood pressure, and 68% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaensler's median patient age at 65, with 38% women.

In 2024, Dr. Gaensler wrote 208 Medicare Part D claims for 26 patients. 71% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $182,705 in total drug cost. In 2023, CMS named 127 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gaensler for performance year 2024, reported as part of a group. Dr. Gaensler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gaensler as offering telehealth.

Dmand AI links 33 papers to Dr. Gaensler, published from 2008 to 2023. 2014 was the busiest year, with 4. The most frequent topics are Hematopoietic Stem Cell Transplantation, Gene Expression and Leukemia, Myeloid, Acute. Dr. Gaensler has published most often in Biol Blood Marrow Transplant. Dr. Gaensler's most frequent co-authors are Lloyd Damon, MD, Rebecca L. Olin, MD and Charalambos I. Andreadis, MD.

CMS Open Payments shows 3 general payments to Dr. Gaensler from 3 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $40.

Dmand AI lists 1 award for Dr. Gaensler, most recently CMS Stage 1 EHR in 2013.

Dr. Gaensler graduated from Harvard Medical School in 1981.

Dr. Gaensler is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.